Innate Pharma S.A. (IPHA)
1.88
0.06 (3.31%)
At close: Apr 11, 2025, 3:50 PM
1.88
0.27%
After-hours: Apr 11, 2025, 05:39 PM EDT
Innate Pharma S.A. Revenue
Innate Pharma S.A. reported an annual revenue of $51.9M, reflecting a 4.56% growth. For the quarter ending June 30, 2024, Innate Pharma S.A. generated $12.35M in revenue.
Revenue (ttm)
$51.9M
Revenue Growth
4.56%
Price / Sales Ratio
4.11
Revenue / Employee
$286.75K
Employees
181
Market Cap
157.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 51.9M | +4.56% |
| Dec 31, 2022 | 49.64M | +309.83% |
| Dec 31, 2021 | 12.11M | -82.64% |
| Dec 31, 2020 | 69.77M | n/a |